Literature DB >> 26250348

Exploration of Male Attitudes on Partnerships and Sexuality with Female BRCA1/2 Mutation Carriers.

Caitlin Mauer1,2, Sara Spencer3, Jeffery Dungan3, Karen Hurley4.   

Abstract

Women with BRCA mutations are inundated with decisions about managing cancer risks and childbearing considerations. Decisions become more complicated when women face disclosing their mutation and risk-reduction options to a romantic partner. This study identifies the concerns and perspectives of male romantic partners regarding these unique decisions. Twenty-five male participants completed an online survey posted to cancer support group message boards. Participants reported relationship changes regarding intimacy levels (n = 9), attraction (n = 2), and communication (n = 22) after mutation disclosure. Participants whose partners had not undergone prophylactic mastectomy (n = 14) reported concerns regarding sexual relations (n = 5), post-surgical appearance (n = 2), post-surgical attraction (n = 5), and health/lifespan (n = 9). Participants did not express attitude changes toward childbearing. While mutation disclosure conversations and surgical options are concerns for many BRCA mutation carriers in relationships, male partners share these concerns. Aspects of the relationship may change, but male study participants continued to support their partners. This information can benefit female BRCA mutation carriers, their current or future partners, and genetic counselors working with this particular population.

Entities:  

Keywords:  Attitudes; BRCA; Cancer; Male partners; Oncology; Risk reducing; Sexuality

Mesh:

Substances:

Year:  2015        PMID: 26250348     DOI: 10.1007/s10897-015-9870-4

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

1.  Increased risk of severe depression in male partners of women with breast cancer.

Authors:  Naoki Nakaya; Kumi Saito-Nakaya; Pernille Envold Bidstrup; Susanne Oksbjerg Dalton; Kirsten Frederiksen; Marianne Steding-Jessen; Yosuke Uchitomi; Christoffer Johansen
Journal:  Cancer       Date:  2010-09-27       Impact factor: 6.860

2.  Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Authors:  Elizabeth Ormondroyd; Louise Donnelly; Clare Moynihan; Cornelie Savona; Elizabeth Bancroft; D Gareth Evans; Rosalind Eeles; Stuart Lavery; Maggie Watson
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

3.  Marital stability after breast cancer.

Authors:  M Dorval; E Maunsell; J Taylor-Brown; M Kilpatrick
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

4.  "In sickness and in health"? Disclosures of genetic risks in dating.

Authors:  Robert L Klitzman; Meghan M Sweeney
Journal:  J Genet Couns       Date:  2010-10-02       Impact factor: 2.537

5.  BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none.

Authors:  Gwendolyn P Quinn; Susan T Vadaparampil; Sharon Tollin; Cheryl A Miree; Devin Murphy; Bethanne Bower; Celso Silva
Journal:  Fertil Steril       Date:  2010-05-05       Impact factor: 7.329

Review 6.  Stress, coping, and social support processes: where are we? What next?

Authors:  P A Thoits
Journal:  J Health Soc Behav       Date:  1995

7.  Effects of spouses on distress experienced by BRCA1 mutation carriers over time.

Authors:  Jean E Wylie; Ken R Smith; Jeffrey R Botkin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2003-05-15       Impact factor: 3.908

8.  Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.

Authors:  Ashley D Staton; Allison W Kurian; Kristin Cobb; Meredith A Mills; James M Ford
Journal:  Fam Cancer       Date:  2007-11-17       Impact factor: 2.375

9.  Psychological adjustment among partners of women at high risk of developing breast/ovarian cancer.

Authors:  Shab Mireskandari; Kerry A Sherman; Bettina Meiser; Alan J Taylor; Margaret Gleeson; Lesley Andrews; Katherine M Tucker
Journal:  Genet Med       Date:  2007-05       Impact factor: 8.822

10.  Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.

Authors:  A Fuchsia Howard; Joan L Bottorff; Lynda G Balneaves; Charmaine Kim-Sing
Journal:  BMC Womens Health       Date:  2010-08-05       Impact factor: 2.809

View more
  5 in total

1.  Identification as a Mutation Carrier and Effects on Life According to Experiences of Finnish Male BRCA1/2 Mutation Carriers.

Authors:  Outi Kajula; Outi Kuismin; Helvi Kyngäs
Journal:  J Genet Couns       Date:  2018-01-13       Impact factor: 2.537

Review 2.  Family Adjustment to Hereditary Cancer Syndromes: A Systematic Review.

Authors:  Pedro Gomes; Giada Pietrabissa; Eunice R Silva; João Silva; Paula Mena Matos; Maria Emília Costa; Vanessa Bertuzzi; Eliana Silva; Maria Carolina Neves; Célia M D Sales
Journal:  Int J Environ Res Public Health       Date:  2022-01-30       Impact factor: 3.390

3.  Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.

Authors:  Boyoung Park; Dongwon Kim; Jiyoung Kim; Bom Yi Lee; Junghyun Yoon; Sung-Won Kim
Journal:  Cancer Res Treat       Date:  2021-08-09       Impact factor: 4.679

4.  Sex Differences in Attitudes Toward Marriage and Childbearing Based on the Assumption of Being BRCA1/2 Mutation Carriers Among Young People.

Authors:  Jiwon Jeong; Boyoung Park; Dongwon Kim; Jiyoung Kim; Bom-Yi Lee; Junghyun Yoon; Sung-Won Kim
Journal:  J Breast Cancer       Date:  2022-06       Impact factor: 2.922

5.  Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA Mutation Carriers With Breast Cancer: A Qualitative Study.

Authors:  Hamizah Sa'at; Yew-Kong Lee; Sook-Yee Yoon; Siu Wan Wong; Yin Ling Woo; Kristine Barlow-Stewart; Nur Aishah Mohd Taib
Journal:  Int J Behav Med       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.